Outcome of patients with advanced solitary fibrous tumors: The Centre Léon Bérard experience

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Levard, Alice ^a   Derbel, Olfa ^a   Méeus, Pierre ^a   Ranchère, Dominique ^a   Ray Coquard, Isabelle ^a   Blay, Jean Yves ^a   Cassier, Philippe A ^a  

^a CENTRE LÉON BÉRARD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BROSTALLICIN; CARBOPLATIN; CISPLATIN; CYTOTOXIC AGENT; DACARBAZINE; DOXORUBICIN; GEMCITABINE; IFOSFAMIDE; IMATINIB; MESNA; NAVELBINE; PACLITAXEL; PALIFOSFAMIDE; PAZOPANIB; PROTEIN TYROSINE KINASE INHIBITOR; SUNITINIB; TRABECTEDIN;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ANOREXIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DIARRHEA; DRUG EFFECT; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HEART FAILURE; HUMAN; MALE; OUTCOME ASSESSMENT; PRIMARY HEALTH CARE; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SIDE EFFECT; SOLITARY FIBROUS TUMOR; SURVIVAL TIME; THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SOLITARY FIBROUS TUMORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84874811673     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-109     Document Type: Article

References (20)

1. Fletcher CD. The evolving classification of soft tissue tumours: an update based on the new WHO classification. Histopathology 2006, 48:3-12. 10.1111/j.1365-2559.2005.02284.x, 16359532.
2. Gengler C, Guillou L. Solitary fibrous tumour and haemangiopericytoma: evolution of a concept. Histopathology 2006, 48:63-74. 10.1111/j.1365-2559.2005.02290.x, 16359538.
3. Brunnemann RB, Ro JY, Ordonez NG, Mooney J, el-Naggar AK, Ayala AG. Extrapleural solitary fibrous tumor: a clinicopathologic study of 24 cases. Mod Pathol 1999, 12:1034-1042.
4. Park MS, Araujo DM. New insights into the hemangiopericytoma/solitary fibrous tumor spectrum of tumors. Curr Opin Oncol 2009, 21:327-331. 10.1097/CCO.0b013e32832c9532, 19444101.
5. Gold JS, Antonescu CR, Hajdu C, Ferrone CR, Hussain M, Lewis JJ. Clinicopathologic correlates of solitary fibrous tumors. Cancer 2002, 94:1057-1068. 10.1002/cncr.10328, 11920476.
6. England DM, Hochholzer L, McCarthy MJ. Localized benign and malignant fibrous tumors of the pleura. A clinicopathologic review of 223 cases. Am J Surg Pathol 1989, 13:640-658. 10.1097/00000478-198908000-00003, 2665534.
7. Spitz FR, Bouvet M, Pisters PW, Pollock RE, Feig BW. Hemangiopericytoma: a 20-year single-institution experience. Ann Surg Oncol 1998, 5:350-355. 10.1007/BF02303499, 9641457.
8. Magdeleinat P, Alifano M, Petino A, Le Rochais JP, Dulmet E, Galateau F. Solitary fibrous tumors of the pleura: clinical characteristics, surgical treatment and outcome. Eur J Cardiothorac Surg 2002, 21:1087-1093. 10.1016/S1010-7940(02)00099-4, 12048090.
9. Constantinidou A, Jones RL, Olmos D, Thway K, Fisher C, Al-Muderis O. Conventional anthracycline-based chemotherapy has limited efficacy in solitary fibrous tumour. Acta Oncol 2012, 51:550-554. 10.3109/0284186X.2011.626450, 22023088.
10. Galanis E, Buckner JC, Scheithauer BW, Kimmel DW, Schomberg PJ, Piepgras DG. Management of recurrent meningeal hemangiopericytoma. Cancer 1998, 82:1915-1920. 10.1002/(SICI)1097-0142(19980515)82:10<1915::AID-CNCR15>3.0.CO;2-W, 9587125.
11. Chaigneau L, Kalbacher E, Thiery-Vuillemin A, Fagnoni-Legat C, Isambert N, Aherfi L. Efficacy of trabectedin in metastatic solitary fibrous tumor. Rare Tumors 2011, 3:e29. 3208416, 22066036.
12. Choi H, Charnsangavej C, Faria SC, Macapinlac HA, Burgess MA, Patel SR. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol 2007, 25:1753-1759. 10.1200/JCO.2006.07.3049, 17470865.
13. Park MS, Patel SR, Ludwig JA, Trent JC, Conrad CA, Lazar AJ. Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer 2011, 117:4939-4947. 10.1002/cncr.26098, 3135685, 21480200.
14. Domont J, Massard C, Lassau N, Armand JP, Le CA, Soria JC. Hemangiopericytoma and antiangiogenic therapy: clinical benefit of antiangiogenic therapy (sorafenib and sunitinib) in relapsed malignant haemangioperyctoma /solitary fibrous tumour. Invest New Drugs 2010, 28:199-202. 10.1007/s10637-009-9249-1, 19352594.
15. de IC-M, Grande-Pulido E, bero-Tamarit A, de Villena ME C-M. Cancer and immune response: old and new evidence for future challenges. Oncologist 2008, 13:1246-1254. 10.1634/theoncologist.2008-0166, 19056856.
16. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000, 92:205-216. 10.1093/jnci/92.3.205, 10655437.
17. Stacchiotti S, Negri T, Libertini M, Palassini E, Marrari A, De TB. Sunitinib malate in solitary fibrous tumor (SFT). Ann Oncol 2012, 23:3171-3179. 10.1093/annonc/mds143, 22711763.
18. George S, Blay JY, Casali PG, Le CA, Stephenson P, DePrimo SE. Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure. Eur J Cancer 2009, 45:1959-1968. 10.1016/j.ejca.2009.02.011, 19282169.
19. Park MS, Ravi V, Araujo DM. Inhibiting the VEGF-VEGFR pathway in angiosarcoma, epithelioid hemangioendothelioma, and hemangiopericytoma/solitary fibrous tumor. Curr Opin Oncol 2010, 22:351-355. 10.1097/CCO.0b013e32833aaad4, 20485168.
20. Chevreau C, Le Cesne A, Ray-Coquard I, Bui Nguyen B, Bompas E, Isambert N. Phase II study of sorafenib mesylate (So) in patients (pts) with evolutive and advanced epithelioid hemangioendothelioma (EHE) or hemangiopericytoma/solitary fibrous tumor (SFT). J Clin Oncol (Meeting Abstracts) 2012, 30:10020.